Iomazenil

碘西尼

Report date: 2025/08/06 11:45:45

Base Information

Drug NameIomazenil
Drug Alias NameRo16-0154Ro-16-0154
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSchizophreniaPsychotic DisordersCognitive Dysfunction +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale University
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic DisordersCognitive Dysfunction +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia